neu LABO is a privately-held biotech roasting and holding company.

neu LABO is unlike a traditional incubator that is tied to a university or research institute, in that it has its own roasting team, and roasts beans from a wide variety of sources.

It is also unlike a typical biotech company that is based on a foundational technology, disease focus or area of biological expertise; and whose goal is to generate a narrow pipeline based on the founding premise.

neu LABO is helmed by a seasoned life sciences investor, thinker and innovator with a deep technical bent, who has had a figurative and literal front-row, in-the-trenches and in-the-Boardroom seat in many areas of innovation over the past two decades.

neu LABO seeks to channel his vision, insights, experience and creativity, while tapping his networks within the academic and biotech community — within a platform setting that is relatively agnostic to area of science or disease focus.  neu LABO’s premise is that technologies within the biotech industry have traditionally been too silo’d; a lot of potential could be unlocked by breaking down those silos.  neu LABO seeks to gently and constructively disrupt these structural constraints, by providing new conduits and resources to grow new beans, and advance new roasts and brews.